GSE159539
CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity
RNA-seq data for candidate genes identified from CRISPR activation screen for tumor immune evasion Overall design: Candidate genes were overexpressed in A375 cells for 7 days before RNA-seq